Retour
Fourchette du Jour
22,40 €
23,82 €
Fourchette 52 Semaines
13,63 €
31,00 €
Volume
1 996 081
Moyenne 50J / 200J
25,19 €
/
23,80 €
Clôture Précédente
24,18 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 1720,7 | 0,3 |
| P/B | 7,7 | 2,9 |
| ROE % | 0,5 | 3,7 |
| Net Margin % | 0,2 | 3,8 |
| Rev Growth 5Y % | 12,7 | 10,0 |
| D/E | 0,6 | 0,2 |
Objectif de Cours des Analystes
Hold
29,33 €
+27.2%
Low: 20,00 €
High: 35,00 €
P/E Prévisionnel
50,2
BPA Prévisionnel
0,48 €
Croissance BPA (est.)
+0,0%
CA Est.
980 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
0,97 €
0,51 € – 1,44 €
|
1,6 B | 2 |
| FY2027 |
0,65 €
0,51 € – 0,73 €
|
1,1 B | 7 |
| FY2026 |
0,48 €
0,39 € – 0,58 €
|
980 M | 7 |
Points Clés
Revenue grew 12,68% annually over 5 years — strong growth
ROE of 0,46% is below average
Generating 43,74M in free cash flow
P/E of 1720,69 — premium valuation
Cash machine — converts 2665,27% of earnings into free cash flow
Capital efficient — spends only 7,69% of revenue on capex
Croissance
Revenue Growth (5Y)
12,68%
Revenue (1Y)13,04%
Earnings (1Y)N/A
FCF Growth (3Y)144,44%
Qualité
Return on Equity
0,46%
ROIC-0,67%
Net Margin0,19%
Op. Margin-0,61%
Sécurité
Debt / Equity
0,63
Current Ratio2,35
Interest Coverage0,00
Valorisation
P/E Ratio
1720,69
P/B Ratio7,68
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13,04% | Revenue Growth (3Y) | 14,10% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 12,68% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 871,91M | Net Income (TTM) | 1,64M |
| ROE | 0,46% | ROA | 0,23% |
| Gross Margin | 53,97% | Operating Margin | -0,61% |
| Net Margin | 0,19% | Free Cash Flow (TTM) | 43,74M |
| ROIC | -0,67% | FCF Growth (3Y) | 144,44% |
| Safety | |||
| Debt / Equity | 0,63 | Current Ratio | 2,35 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 1720,69 | P/B Ratio | 7,68 |
| P/S Ratio | 3,24 | PEG Ratio | -15,10 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,82B | Enterprise Value | 2,77B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 871,91M | 771,32M | 669,77M | 598,11M | 540,80M |
| Net Income | 1,64M | -20,39M | -63,20M | -110,39M | -144,27M |
| EPS (Diluted) | 0,01 | -0,17 | -0,54 | -0,96 | -1,39 |
| Gross Profit | 470,58M | 426,83M | 365,22M | 341,06M | 317,75M |
| Operating Income | -5,34M | -30,11M | -72,00M | -111,20M | -143,66M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 720,92M | 676,49M | 580,31M | 568,71M | 440,65M |
| Total Liabilities | 353,19M | 336,42M | 278,53M | 282,06M | 154,65M |
| Shareholders' Equity | 367,73M | 340,07M | 301,79M | 286,65M | 286,00M |
| Total Debt | 233,15M | 225,36M | 174,46M | 173,38M | 0,0 |
| Cash & Equivalents | 286,36M | 254,16M | 216,89M | 208,59M | 256,42M |
| Current Assets | 352,44M | 326,05M | 298,62M | 294,57M | 327,98M |
| Current Liabilities | 150,13M | 130,35M | 127,09M | 129,56M | 118,10M |